AngioChem angiochem.com


Public lists: Pharma Startups (4732)

AngioChem is a clinical-stage biotechnology discovering and developing new breakthrough drugs that are capable of crossing the blood-brain barrier to treat brain diseases. The company's EPiC platform aims to solve the key problem for crossing the blood-brain barrier by developing drugs that use a receptor-based approach. These novel Engineered Peptide Compounds (EPiC) have the potential, per AngioChem, to address significant medical needs, many of which cannot be effectively addressed due to the...Show all

AngioChem is a clinical-stage biotechnology discovering and developing new breakthrough drugs that are capable of crossing the blood-brain barrier to treat brain diseases. The company's EPiC platform aims to solve the key problem for crossing the blo...Show all

Company (Alive / Active)

Phone: 514-788-7800

Fax: : 514-788-7801

201 President-Kennedy Ave.
Suite PK-R220
Montreal, H2X 3Y7
Quebec, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
AngioChem $11.8M Aug 1, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related AngioChem Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Competitors

Company Status Description Investors

Avera Pharmaceuticals

San Diego, California, United States
Dead / InactiveAvera is a development stage biotechnology company developing drugs to treat diseases of the central nervous systemAvera PharmaceuticalsLogin to see details

Cerecin

Singapore
Alive / ActiveCerecin, fka Accera, is a biopharmaceutical company with a drug for Alzheimer's in late stage clinical testing. Accera's pipeline consists of therapeutic drugs and medical foods for neurodegenerative diseases such as Alzheimer's, Parkinson's, and Age Associated Memory Impairment. The company was previously based in Colorado, USA.Login to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Conjugates of neurotensin or neurotensin analogs and uses thereof Dec 07, 2009 Mar 13, 2018 Patent
Potentiation of anticancer agents Mar 02, 2015 Jul 25, 2017 Patent
Peptide-dendrimer conjugates and uses thereof Aug 14, 2013 Jun 27, 2017 Patent
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues May 29, 2008 Jun 14, 2016 Patent
Method for transporting a compound across the blood-brain barrier Jan 05, 2004 Dec 29, 2015 Patent
See all 33 patents